mrt-6160
·Code: MRT-6160
mrt-6160: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | Phase 1 |
Clinical Trials (1)
Phase 1, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose, and Food-Effect Study to Assess Safety, Tolerability, PK and PD of MRT-6160 in Healthy Subjects
Frequently asked questions
Who is developing mrt-6160?
mrt-6160 is being developed by Monte Rosa Therapeutics, Inc..
How many clinical trials involve mrt-6160?
BioSniper tracks 1 clinical trial involving mrt-6160.
Get deeper analysis on mrt-6160
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis